TORONTO DOMINION BANK

Bank

Position in PTCT — Ptc Therapeutics, Inc.

CIK 947263 TORONTO, ONTARIO, A6

Position in PTCT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$206,158,858

-$108,179,953 QoQ

Shares Held

3,025,963

-26.9% QoQ

Ownership

3.65%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

7 quarters on record

Voting authority Sole 99.99940514804709.ToString("F0")% Shared 0.0005948519529154851.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TORONTO DOMINION BANK holds $906,007,871 across 49 Biotechnology names. PTCT ranks #1 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTCT	Ptc Therapeutics, Inc. This page	3,025,963	$206,158,858
2	STOK	Stoke Therapeutics, Inc.	3,173,258	$103,321,280
3	CELC	Celcuity Inc.	882,758	$100,757,998
4	IMTX	Immatics N.V.	7,436,342	$73,173,605
5	MDGL	Madrigal Pharmaceuticals, Inc.	130,460	$68,291,895
6	APLS	Apellis Pharmaceuticals, Inc.	1,236,436	$49,741,820
7	URGN	UroGen Pharma Ltd.	2,616,714	$47,048,517
8	TERN	Terns Pharmaceuticals, Inc.	781,800	$41,216,496

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$206,158,858	3,025,963	-26.9%	Shares	Defined	2026-05-15
2025-12-31	$314,338,811	4,138,215	0.0%	Shares	Sole	2026-02-17
2025-12-31	$314,338,811	4,138,215	+27.5%	Shares	Sole	2026-02-13
2025-09-30	$199,239,239	3,246,525	+32.7%	Shares	Defined	2025-11-14
2025-06-30	$119,460,588	2,445,958	-6.4%	Shares	Defined	2025-08-14
2025-03-31	$133,168,468	2,613,196	-20.5%	Shares	Defined	2025-05-15
2024-12-31	$148,362,947	3,286,729	+4282.2%	Shares	Defined	2025-02-19
2021-12-31	$2,987,289	75,001	—	Shares	Sole	2022-02-04
No filing history on record for this holder in this stock.